Sitara Peroxide Statistics
Total Valuation
Sitara Peroxide has a market cap or net worth of PKR 745.50 million. The enterprise value is 1.40 billion.
Market Cap | 745.50M |
Enterprise Value | 1.40B |
Important Dates
The next estimated earnings date is Friday, February 21, 2025.
Earnings Date | Feb 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Sitara Peroxide has 55.10 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 55.10M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | -0.09% |
Owned by Insiders (%) | 44.99% |
Owned by Institutions (%) | n/a |
Float | 26.34M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.42 |
PB Ratio | 0.60 |
P/TBV Ratio | 0.60 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.84 |
EV / Sales | 2.67 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -15.64 |
Financial Position
The company has a current ratio of 0.45, with a Debt / Equity ratio of 0.53.
Current Ratio | 0.45 |
Quick Ratio | 0.16 |
Debt / Equity | 0.53 |
Debt / EBITDA | n/a |
Debt / FCF | -7.32 |
Interest Coverage | -12.42 |
Financial Efficiency
Return on equity (ROE) is -46.66% and return on invested capital (ROIC) is -18.64%.
Return on Equity (ROE) | -46.66% |
Return on Assets (ROA) | -11.51% |
Return on Capital (ROIC) | -18.64% |
Revenue Per Employee | 2.00M |
Profits Per Employee | -2.91M |
Employee Count | 262 |
Asset Turnover | 0.14 |
Inventory Turnover | 2.26 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -11.03% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -11.03% |
50-Day Moving Average | 13.46 |
200-Day Moving Average | 13.44 |
Relative Strength Index (RSI) | 48.15 |
Average Volume (20 Days) | 30,027 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sitara Peroxide had revenue of PKR 524.72 million and -762.54 million in losses. Loss per share was -13.84.
Revenue | 524.72M |
Gross Profit | -282.79M |
Operating Income | -669.45M |
Pretax Income | -727.51M |
Net Income | -762.54M |
EBITDA | -486.75M |
EBIT | -669.45M |
Loss Per Share | -13.84 |
Balance Sheet
The company has 1.18 million in cash and 654.96 million in debt, giving a net cash position of -653.79 million or -11.87 per share.
Cash & Cash Equivalents | 1.18M |
Total Debt | 654.96M |
Net Cash | -653.79M |
Net Cash Per Share | -11.87 |
Equity (Book Value) | 1.24B |
Book Value Per Share | 22.54 |
Working Capital | -827.79M |
Cash Flow
In the last 12 months, operating cash flow was -80.91 million and capital expenditures -8.56 million, giving a free cash flow of -89.46 million.
Operating Cash Flow | -80.91M |
Capital Expenditures | -8.56M |
Free Cash Flow | -89.46M |
FCF Per Share | -1.62 |
Margins
Gross margin is -53.89%, with operating and profit margins of -127.58% and -145.32%.
Gross Margin | -53.89% |
Operating Margin | -127.58% |
Pretax Margin | -138.65% |
Profit Margin | -145.32% |
EBITDA Margin | -92.77% |
EBIT Margin | -127.58% |
FCF Margin | n/a |
Dividends & Yields
Sitara Peroxide does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.01% |
Shareholder Yield | 0.01% |
Earnings Yield | -102.27% |
FCF Yield | -12.00% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Sitara Peroxide has an Altman Z-Score of -0.86. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -0.86 |
Piotroski F-Score | n/a |